{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:40:10Z","timestamp":1787064010988,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"vor","delay-in-days":28,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ejca.2019.10.009","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T19:34:21Z","timestamp":1574364861000},"page":"102-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Oral contraceptive and intrauterine device use and the risk of cervical intraepithelial neoplasia grade III or worse: a population-based study"],"prefix":"10.1016","volume":"124","author":[{"given":"Diede L.","family":"Loopik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"IntHout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem J.G.","family":"Melchers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon F.A.G.","family":"Massuger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruud L.M.","family":"Bekkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert G.","family":"Siebers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejca.2019.10.009_bib1","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jcp.55.4.244","article-title":"The causal relation between human papillomavirus and cervical cancer","volume":"55","author":"Bosch","year":"2002","journal-title":"J Clin Pathol"},{"issue":"6","key":"10.1016\/j.ejca.2019.10.009_bib2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1473-3099(09)70108-2","article-title":"Clinician's guide to human papillomavirus immunology: knowns and unknowns","volume":"9","author":"Einstein","year":"2009","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.ejca.2019.10.009_bib3","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/path.2192","article-title":"Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis?","volume":"212","author":"Pett","year":"2007","journal-title":"J Pathol"},{"issue":"2","key":"10.1016\/j.ejca.2019.10.009_bib4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0168-1702(02)00188-0","article-title":"Environmental co-factors in HPV carcinogenesis","volume":"89","author":"Castellsague","year":"2002","journal-title":"Virus Res"},{"issue":"Suppl 3","key":"10.1016\/j.ejca.2019.10.009_bib5","article-title":"Chapter 1: HPV in the etiology of human cancer","volume":"24","author":"Munoz","year":"2006","journal-title":"Vaccine"},{"issue":"9364","key":"10.1016\/j.ejca.2019.10.009_bib6","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(03)12949-2","article-title":"Cervical cancer and use of hormonal contraceptives: a systematic review","volume":"361","author":"Smith","year":"2003","journal-title":"Lancet (London, Engl)"},{"issue":"4","key":"10.1016\/j.ejca.2019.10.009_bib7","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ajog.2016.11.1053","article-title":"The effect of intrauterine devices on acquisition and clearance of human papillomavirus","volume":"216","author":"Averbach","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.ejca.2019.10.009_bib8","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1470-2045(11)70223-6","article-title":"Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies","volume":"12","author":"Castellsague","year":"2011","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2019.10.009_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147029","article-title":"The influence of hormonal factors on the risk of developing cervical cancer and pre-cancer: results from the EPIC cohort","volume":"11","author":"Roura","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ejca.2019.10.009_bib10","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/bjc.2012.513","article-title":"Parity as a cofactor for high-grade cervical disease among women with persistent human papillomavirus infection: a 13-year follow-up","volume":"108","author":"Jensen","year":"2013","journal-title":"Br J Canc"},{"issue":"6","key":"10.1016\/j.ejca.2019.10.009_bib11","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/AOG.0000000000002307","article-title":"Intrauterine device use and cervical cancer risk: a systematic review and meta-analysis","volume":"130","author":"Cortessis","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejca.2019.10.009_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2018.04.008","article-title":"Recent intrauterine device use and the risk of precancerous cervical lesions and cervical cancer","author":"Averbach","year":"2018","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.ejca.2019.10.009_bib13","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/jcp.2003.011841","article-title":"The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996","volume":"57","author":"Bulk","year":"2004","journal-title":"J Clin Pathol"},{"issue":"6c","key":"10.1016\/j.ejca.2019.10.009_bib14","first-page":"4729","article-title":"Oral contraceptives are not an independent risk factor for cervical intraepithelial neoplasia or high-risk human papillomavirus infections","volume":"26","author":"Syrjanen","year":"2006","journal-title":"Anticancer Res"},{"issue":"5","key":"10.1016\/j.ejca.2019.10.009_bib15","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/AOG.0000000000000760","article-title":"Comparison of human papillomavirus infection and cervical cytology in women using copper-containing and levonorgestrel-containing intrauterine devices","volume":"125","author":"Lekovich","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"1\u20132","key":"10.1016\/j.ejca.2019.10.009_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2006.10.014","article-title":"Role of hormone cofactors in the human papillomavirus-induced carcinogenesis of the uterine cervix","volume":"264","author":"Delvenne","year":"2007","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10.1016\/j.ejca.2019.10.009_bib17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/07357909909011713","article-title":"Altered growth and viral gene expression in human papillomavirus type 16-containing cancer cell lines treated with progesterone","volume":"17","author":"Yuan","year":"1999","journal-title":"Cancer Invest"},{"issue":"3","key":"10.1016\/j.ejca.2019.10.009_bib18","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/sj.bjc.6603260","article-title":"Oral contraceptive use and cancer. Findings in a large cohort study, 1968-2004","volume":"95","author":"Vessey","year":"2006","journal-title":"Br J Canc"},{"issue":"2","key":"10.1016\/j.ejca.2019.10.009_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/ijgc-00009577-200303000-00001","article-title":"The role of steroid contraceptive hormones in the pathogenesis of invasive cervical cancer: a review","volume":"13","author":"Moodley","year":"2003","journal-title":"Int Gynecol Cancer Soc"},{"issue":"6","key":"10.1016\/j.ejca.2019.10.009_bib20","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ajog.2017.02.002","article-title":"Lifetime cancer risk and combined oral contraceptives: the royal college of general practitioners' oral contraception study","volume":"216","author":"Iversen","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ejca.2019.10.009_bib21","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/jamaoncol.2017.4942","article-title":"Modification of the associations between duration of oral contraceptive use and ovarian, endometrial, breast, and colorectal cancers","volume":"4","author":"Michels","year":"2018","journal-title":"JAMA oncology"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804919307725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804919307725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:26:19Z","timestamp":1760732779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804919307725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":21,"alternative-id":["S0959804919307725"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2019.10.009","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral contraceptive and intrauterine device use and the risk of cervical intraepithelial neoplasia grade III or worse: a population-based study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2019.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}